Catalyst
Slingshot members are tracking this event:
Valeant and Progenics Announce FDA Approves RELISTOR Tablets (450 mg once daily) for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 19, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Relistor, Opioid-induced Constipation, Chronic Non-cancer Pain, Methylnaltrexone Bromide, Opioid Therapy
